These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 15756102)

  • 1. Cirrhosis related chylous ascites successfully treated with TIPS.
    de Vries GJ; Ryan BM; de Bièvre M; Driessen A; Stockbrugger RW; Koek GH
    Eur J Gastroenterol Hepatol; 2005 Apr; 17(4):463-6. PubMed ID: 15756102
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transjugular Intrahepatic Portosystemic Shunt for the Treatment of Chylothorax and Chylous Ascites in Cirrhosis: A Case Report and Systematic Review of the Literature.
    Tsauo J; Shin JH; Han K; Yoon HK; Ko GY; Ko HK; Gwon DI
    J Vasc Interv Radiol; 2016 Jan; 27(1):112-6. PubMed ID: 26723922
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transjugular intrahepatic portosystemic shunt creation as treatment for refractory chylous ascites and chylothorax in a patient with cirrhosis.
    Kinney TB; Ferrara SL; Miller FJ; Roberts AC; Hassanein T
    J Vasc Interv Radiol; 2004 Jan; 15(1 Pt 1):85-9. PubMed ID: 14709693
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transjugular intrahepatic portosystemic shunt for treatment of cirrhosis-related chylothorax and chylous ascites: single-institution retrospective experience.
    Kikolski SG; Aryafar H; Rose SC; Roberts AC; Kinney TB
    Cardiovasc Intervent Radiol; 2013 Aug; 36(4):992-7. PubMed ID: 23207657
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of orlistat (xenical) to treat chylous ascites.
    Chen J; Lin RK; Hassanein T
    J Clin Gastroenterol; 2005 Oct; 39(9):831-3. PubMed ID: 16145348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Chylous ascites and TIPS].
    Vargas L; Lobo S; Agar S; Rodríguez A; Soto JR
    Rev Med Chil; 1997 Feb; 125(2):220-1. PubMed ID: 9430944
    [No Abstract]   [Full Text] [Related]  

  • 7. Refractory Chylous Ascites with Chylothorax and an Umbilical Hernia in a Patient Ineligible for a Transjugular Intrahepatic Portosystemic Shunt.
    Fatah A; Audiyanto T
    Am J Case Rep; 2020 Aug; 21():e925026. PubMed ID: 32865187
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Dysfunction of a TIPS (transjugular intrahepatic porto-systemic shunt) and chylous ascites].
    Rovira E; Molés JR; Hinojosa J; Primo J; Gonzalvo F; Albert A
    Rev Esp Enferm Dig; 1997 Jun; 89(6):475-7. PubMed ID: 9303612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Management of chylous ascites and chylothorax. Report of one case].
    Jofré P; Grassi B; Benítez C
    Rev Med Chil; 2020 Aug; 148(8):1202-1206. PubMed ID: 33399787
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thoracic duct-cutaneous fistula in a patient with cirrhosis of the liver: successful treatment with a transjugular intrahepatic portosystemic shunt.
    Rosser BG; Poterucha JJ; McKusick MA; Kamath PS
    Mayo Clin Proc; 1996 Aug; 71(8):793-6. PubMed ID: 8691901
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transient chylous ascites following a distal splenorenal shunt.
    Edoute Y; Nagachandran P; Assalia A; Ben-Ami H
    Hepatogastroenterology; 2000; 47(32):531-2. PubMed ID: 10791230
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Review article: the diagnostic approach and current management of chylous ascites.
    Lizaola B; Bonder A; Trivedi HD; Tapper EB; Cardenas A
    Aliment Pharmacol Ther; 2017 Nov; 46(9):816-824. PubMed ID: 28892178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Type-2 hepatorenal syndrome and refractory ascites: role of transjugular intrahepatic portosystemic stent-shunt in eighteen patients with advanced cirrhosis awaiting orthotopic liver transplantation.
    Testino G; Ferro C; Sumberaz A; Messa P; Morelli N; Guadagni B; Ardizzone G; Valente U
    Hepatogastroenterology; 2003; 50(54):1753-5. PubMed ID: 14696397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term renal sodium handling in patients with cirrhosis treated with transjugular intrahepatic portosystemic shunts for refractory ascites.
    Wong W; Liu P; Blendis L; Wong F
    Am J Med; 1999 Mar; 106(3):315-22. PubMed ID: 10190381
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Successful treatment of refractory ascites in a child with transjugular intrahepatic portosystemic shunt.
    Lee WS; McKiernan PJ; de Ville de Goyet JV; Tanner MS; John PR
    Acta Paediatr; 2001 Nov; 90(11):1352-5. PubMed ID: 11808914
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term clinical outcome of patients with cirrhosis and refractory ascites treated with transjugular intrahepatic portosystemic shunt insertion.
    Tan HK; James PD; Sniderman KW; Wong F
    J Gastroenterol Hepatol; 2015 Feb; 30(2):389-95. PubMed ID: 25168607
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transjugular intrahepatic portosystemic shunt for cirrhosis and ascites: Effects in patients with organic or functional renal failure.
    Michl P; Gülberg V; Bilzer M; Waggershauser T; Reiser M; Gerbes AL
    Scand J Gastroenterol; 2000 Jun; 35(6):654-8. PubMed ID: 10912668
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spontaneous chylous ascites of cirrhosis.
    Rector WG
    J Clin Gastroenterol; 1984 Aug; 6(4):369-72. PubMed ID: 6481122
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transjugular intrahepatic portosystemic shunt placement for refractory ascites: a single-centre experience.
    Lodato F; Berzigotti A; Lisotti A; Azzaroli F; Mosconi C; Giampalma E; Renzulli M; Cappelli A; Buonfiglioli F; Calvanese C; Zoli M; Golfieri R; Mazzella G
    Scand J Gastroenterol; 2012 Dec; 47(12):1494-500. PubMed ID: 22958120
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chylous ascites in cirrhosis: a case report and review of the literature.
    Cheng WS; Gough IR; Ward M; Croese J; Powell LW
    J Gastroenterol Hepatol; 1989; 4(1):95-9. PubMed ID: 2490947
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.